| Bernesta Charntel Williams, MD | |
|
202 E Grover St, Ste 1, Shelby, NC 28150-3977 | |
| (980) 487-2360 | |
| Not Available |
| Full Name | Bernesta Charntel Williams |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Neurology |
| Location | 202 E Grover St, Shelby, North Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982804183 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084S0012X | Psychiatry & Neurology - Sleep Medicine | 2023-02283 (North Carolina) | Secondary |
| 2084N0400X | Psychiatry & Neurology - Neurology | 2023-02283 (North Carolina) | Primary |
| Entity Name | Carolinas Physicians Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437607686 PECOS PAC ID: 3375449655 Enrollment ID: O20040115000819 |
News Archive
Cadence Pharmaceuticals, Inc., a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that it has signed an agreement providing Cadence with an exclusive option to acquire Incline Therapeutics, Inc., a privately held specialty pharmaceutical company.
Cervical cancer can be insidious. Changes to the cervix are often detected with a pap smear, but for those with limited access to health care, cervical and vaginal cancers can go unnoticed for years-silently growing, spreading and invading other organs-and by the time they're detected, they may be so advanced that the patient's prognosis is poor and her treatment options few.
ProFibrix B.V., a leader in the development of innovative products for hemostasis and regenerative medicine, today announced the conclusion of the first Phase II trial testing its unique new hemostat Fibrocaps(TM). Promising preliminary data from the European multicenter, open-label trial show compelling safety and efficacy (time to hemostasis) profiles for Fibrocaps, and good performance of the delivery device.
Imagine tying your shoes or taking a sip of coffee or cracking an egg but without any feeling in your hand.That's life for users of even the most advanced prosthetic arms.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bernesta Charntel Williams, MD Po Box 19305, Charlotte, NC 28219-9305 Ph: () - | Bernesta Charntel Williams, MD 202 E Grover St, Ste 1, Shelby, NC 28150-3977 Ph: (980) 487-2360 |
News Archive
Cadence Pharmaceuticals, Inc., a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that it has signed an agreement providing Cadence with an exclusive option to acquire Incline Therapeutics, Inc., a privately held specialty pharmaceutical company.
Cervical cancer can be insidious. Changes to the cervix are often detected with a pap smear, but for those with limited access to health care, cervical and vaginal cancers can go unnoticed for years-silently growing, spreading and invading other organs-and by the time they're detected, they may be so advanced that the patient's prognosis is poor and her treatment options few.
ProFibrix B.V., a leader in the development of innovative products for hemostasis and regenerative medicine, today announced the conclusion of the first Phase II trial testing its unique new hemostat Fibrocaps(TM). Promising preliminary data from the European multicenter, open-label trial show compelling safety and efficacy (time to hemostasis) profiles for Fibrocaps, and good performance of the delivery device.
Imagine tying your shoes or taking a sip of coffee or cracking an egg but without any feeling in your hand.That's life for users of even the most advanced prosthetic arms.
› Verified 4 days ago
Dr. John M Billinsky Jr., MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 201 E Grover St, Shelby, NC 28150 Phone: 980-487-3929 Fax: 980-487-3931 | |
Dr. Kerry Layne Balentine, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 418 S. Washington St., Shelby, NC 28150 Phone: 704-692-9380 Fax: 833-605-5203 | |
Hos Cyrus Loftus, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 202 E Grover St, Ste 1, Shelby, NC 28150 Phone: 980-487-2360 | |
Kevin M. Klein, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 202 E Grover St, Ste 1, Shelby, NC 28150 Phone: 980-487-2360 | |
Howard K Mason, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1201 S Post Rd Ste 100, Shelby, NC 28152 Phone: 704-481-7001 Fax: 704-445-4582 | |
Robert Bruce Thompson, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 419 Earl Road, Shelby, NC 28150 Phone: 704-481-0555 Fax: 704-481-9169 |